Ra Medical Systems, Inc. (RMED) financial statements (2021 and earlier)

Company profile

Business Address 2070 LAS PALMAS DRIVE
CARLSBAD, CA 92011
State of Incorp.
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:24342923311512
Cash and cash equivalents24342918151512
Other undisclosed cash, cash equivalents, and short-term investments   516  
Receivables0001111
Inventory, net of allowances, customer advances and progress billings2333332
Inventory2333332
Deferred costs 00    
Other undisclosed current assets101222738
Total current assets:28373429364553
Noncurrent Assets
Operating lease, right-of-use asset233333 
Property, plant and equipment3445556
Other noncurrent assets0000000
Other undisclosed noncurrent assets      3
Total noncurrent assets:6678899
TOTAL ASSETS:33434136445462
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5563454
Accounts payable1121212
Accrued liabilities4542342
Deferred revenue222222 
Debt00 000 
Contract with customer, liability2
Other undisclosed current liabilities1110001
Total current liabilities:8886786
Noncurrent Liabilities
Long-term debt and lease obligation222333 
Operating lease, liability222333 
Liabilities, other than long-term debt1111111
Deferred revenue111111 
Contract with customer, liability1
Other undisclosed noncurrent liabilities2220003
Total noncurrent liabilities:5554444
Total liabilities:12131410111211
Stockholders' equity
Stockholders' equity attributable to parent21312726334252
Common stock0000000
Additional paid in capital174173162151150149142
Accumulated other comprehensive income   0000
Accumulated deficit(153)(143)(135)(125)(117)(107)(90)
Total stockholders' equity:21312726334252
TOTAL LIABILITIES AND EQUITY:33434136445462

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues1111122
Cost of revenue
(Cost of Goods and Services Sold)
(1)(1)(1)(2)(2)(2)(3)
Gross profit:(0)(1)(0)(0)(0)(1)(1)
Operating expenses(10)(7)(10)(8)(9)(17)(15)
Operating loss:(10)(8)(10)(8)(10)(18)(15)
Nonoperating income (expense)(0)(0)(0)0000
Investment income, nonoperating0000000
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(10)(8)(10)(8)(10)(17)(15)
Other undisclosed income from continuing operations before income taxes0000000
Loss from continuing operations before income taxes:(10)(8)(10)(8)(10)(17)(15)
Income tax expense    (0)(0)(0)
Other undisclosed loss from continuing operations(0)      
Net loss available to common stockholders, diluted:(10)(8)(10)(8)(10)(17)(15)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(10)(8)(10)(8)(10)(17)(15)
Other comprehensive income (loss)  (0)(0)(0)(0)0
Comprehensive loss, net of tax, attributable to parent:(10)(8)(10)(8)(10)(17)(15)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: